Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 8781-8790 of 13616

Page
per page
  1. GDC-0980 (RG7422)
    B2184 GDC-0980 (RG7422)
    Summary: Class I PI3K inhibitor for PI3Kα/β/δ/γ
      ≥21.35 mg/mL
  2. TAK-733
    B1621 TAK-733
    Target: MEK
    Summary: MEK allosteric site inhibitor
      ≥25.2 mg/mL
  3. Amsacrine hydrochloride
    B1303 Amsacrine hydrochloride
    Summary: Topoisomerase 2 inhibitor
      ≥55.56 mg/mL
  4. MMP-2 Inhibitor I
    C5615 MMP-2 Inhibitor I
    Summary: reversible inhibitor of matrix metalloproteinase (MMP)-2
      ≤50 mg/mL
  5. Angiotensin 1/2 (1-5)
    A1047 Angiotensin 1/2 (1-5)
    Summary: Vasoconstrictor
      insoluble in H2O; ≥66.5 mg/mL
  6. TBK1/IKKε-IN-5
    B8540 TBK1/IKKε-IN-5
    Summary: Dual TBK1 and IKKε inhibitor
      ≥9.02 mg/mL
  7. Fenofibric acid
    B6128 Fenofibric acid
    Summary: ppar inhibitor， lipid-lowering agent
      ≥31.9 mg/mL
  8. Pamapimod (R-1503, Ro4402257)
    B6188 Pamapimod (R-1503, Ro4402257)
    Summary: p38 MAPK inhibitor
      Soluble in DMSO
  9. AMG 337
    B6193 AMG 337
    Summary: MET inhibitor
      ≥46.3 mg/mL
  10. AG-221 (Enasidenib)
    B7804 AG-221 (Enasidenib)
     1 Citation
    Summary: mutant isocitrate dehydrogenase 2 (IDH2) inhibitor
      ≥47.3 mg/mL

Items 8781-8790 of 13616

Page
per page